← All companies

MNZO

Manzo Pharmaceuticals, Inc.

MNZO Crude Petroleum & Natural Gas EDGAR ↗

$0.00

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

—

Recent SEC filings

36 most recent

Annual, quarterly & current reports

8-K Other events Apr 12, 2006 8-K Other events Jan 12, 2006 8-K Other events Dec 14, 2005 8-K Other events Nov 4, 2005 8-K Other events Oct 13, 2005

Other filings

D Item 06c Feb 27, 2025 D/A Item 06c Feb 10, 2025 D Item 06c May 21, 2024 D Item 04 Mar 25, 2011 15-12G CERTIFICATION AND NOTICE OF TERMINATION Jul 30, 2010 5/A Mar 2, 2007 5 Feb 13, 2007 NT 10-Q Apr 28, 2006 UPLOAD Apr 26, 2006 UPLOAD Apr 26, 2006 UPLOAD Apr 10, 2006 UPLOAD Apr 10, 2006 NT 10-K Mar 28, 2006 CORRESP Mar 10, 2006 10SB12G/A Mar 10, 2006 5 Feb 13, 2006 5 Feb 13, 2006 10SB12G/A Feb 8, 2006 CORRESP Feb 8, 2006 10QSB/A Feb 8, 2006 UPLOAD Dec 30, 2005 10SB12G/A Dec 22, 2005 10QSB Nov 16, 2005 NT 10-Q Nov 15, 2005 CORRESP Oct 26, 2005 10SB12G/A Oct 18, 2005 3/A Oct 14, 2005 3/A Oct 14, 2005 3 Oct 11, 2005 3 Oct 7, 2005 10SB12G Aug 8, 2005